Camobucol - Moligand™, 10 mM in DMSO , CAS No.216167-92-9

CAS: 216167-92-9 Cat. No.: C1497582 Summenformel: C33H50O4S2 Molekulargewicht: 574.88 PubChem CID: 9875498
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10 mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1ml
C1497582-1ml
Auf Bestellung · 8–12 Wochen
520,56€
Enter a quantity for the sizes you want to add.

Übersicht

Camobucol (AGIX 4207) is an orally active, phenolic antioxidant and anti-inflammatory compound with antirheumatic properties.

Spezifikationen

Spezifikationen & Reinheit
Moligand™, 10 mM in DMSO
Storage
Store at -80°C
Verschickt in
Dry ice packs + Cold packs
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Namen und Kennungen
Isomere SMILES
CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)OCC(=O)O)C(C)(C)C
Alternative CAS-Nummer
216167-92-9
PubChem CID
9875498
MeSH-Eintrag
(4-((1-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio)-1-methylethyl)thio)-2,6-bis(1,1-dimethylethyl)phenoxy)acetic acid;AGIX 4207;AGIX-4207;AGIX4207;camobucol;ylgucpd100bdh
Molekulargewicht
574.88

Erweiterte Daten

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

No validated application protocols are provided for this item in the product data.

General HTS/assay workflow (for guidance; adapt to your system)

  • Stock solution: Prepare 10 mM in anhydrous DMSO (or as solubility permits). Aliquot and store at -80°C to limit freeze–thaw.
  • Plate handling: Thaw on ice or at 4°C; centrifuge briefly to collect condensate; mix thoroughly before dispensing. Use acoustic or pin-tool transfer for low-volume accuracy.
  • Assay addition: Target ≤0.5–1% DMSO final. Include vehicle controls, positive controls (where applicable), and at least 8-point serial dilutions for CRCs.
  • Data quality: Monitor Z’ factor, include duplicates/triplicates, and perform post-screen confirmation with freshly prepared stocks.

Note: The above is general practice for small-molecule screening and is not an item-specific validated protocol.

Biological Roles

Item-specific biological function, targets, and pathways for Camobucol are not provided in the product data. No claims are made regarding its biological activity or mechanism.

General considerations for small-molecule library members (not item-specific)

  • Screening role: Library compounds are evaluated as potential ligands/modulators across biochemical or cellular assays to discover structure–activity relationships (SAR).
  • Profiling: Hits typically undergo broad off-target panels and physicochemical property profiling (e.g., solubility, stability, permeability) to contextualize observed activity.
  • Aggregation/assay interference: Some scaffolds may act as colloidal aggregators or redox cyclers; deploy appropriate controls (detergent, counterscreens, orthogonal readouts).

Research-use limitation

  • For research use only. Not intended for diagnostic, therapeutic, or clinical applications. Any biological roles must be established experimentally by the end user or provided by the manufacturer’s CoA/technical note.
Buffer Applications

This product is a small-molecule screening compound rather than a buffering reagent. Therefore, conventional buffer system guidance (pH range, recipes) is not typically applicable.

Practical notes (general assay context)

  • Delivery into buffers: Prepare concentrated DMSO stocks and dilute into assay buffers at low final DMSO fractions to maintain buffer capacity and assay performance.
  • Surfactants: For hydrophobic compounds, incorporating 0.01–0.05% nonionic surfactant can mitigate nonspecific adsorption and aggregation in buffered media.

For buffer formulation details, refer to standard biochemical buffers (e.g., phosphate, HEPES, Tris) appropriate to your assay rather than the compound itself.

Green Alternatives

Sustainability guidance focuses on solvent and process choices around Camobucol’s use, since the compound’s intrinsic structure and synthesis are not provided.

  • Greener handling of stock solutions (general)

    • Prefer aqueous-compatible delivery from concentrated DMSO stocks at ≤1% final v/v to reduce organic solvent use in assays.
    • Consider bio-based or lower-toxicity solvents for preparative work where compatible (e.g., ethanol, 2-propanol) instead of higher-toxicity amide solvents.
  • Solvent alternatives (general comparison; not item-specific)

    Greener option vs conventional:

    • 2-Methyltetrahydrofuran (2-MeTHF) vs THF: bio-derived, higher boiling, lower peroxide risk than ethers like diethyl ether; check solubility.
    • Cyrene or GBL vs DMF/DMAc: potential drop-in for some reactions or extractions; assess stability and solubilizing power.
    • Ethyl acetate vs dichloromethane for workups and chromatography when feasible.
  • Operational measures

    • Scale stocks appropriately to minimize waste; use inert gas blankets and crimp-sealed vials to extend lifetime of DMSO solutions, reducing remakes.
    • Implement microplate-based solubility screens to avoid preparing excessive volumes of poorly soluble working solutions.

Tradeoffs: Greener solvents may alter solubility, assay backgrounds, or evaporation rates; validate with small pilots before full deployment.

Pharmaceutical Uses

No pharmacopeial status or excipient role is provided for Camobucol, and it is offered strictly for research use only.

Context for researchers (general, non-clinical)

  • Discovery stage: Small-molecule library members like Camobucol may be evaluated as starting points for medicinal chemistry programs, but any such use requires independent characterization and is outside the scope of the supplied product.
  • Manufacturing/CMC: There are no claims regarding GMP status, impurity profiles, or suitability for human or veterinary use.

Compliance note

  • Do not use in humans or for diagnostic procedures. For any regulated applications, obtain appropriate grade material and regulatory documentation.
Physical Properties

Item-specific physicochemical specifications have not been provided in the product data.

  • Item-specific specs
    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
    • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
    • Density: Not specified for this item; refer to CoA/Spec Sheet.
    • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
    • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
    • pKa: Not specified for this item; refer to CoA/Spec Sheet.
    • Refractive index/UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for library compounds (literature/practice, not specifications)

  • Many screening compounds are provided as dry films or DMSO solutions; if provided neat, they are commonly reconstituted in anhydrous DMSO for primary stocks (typically 10–50 mM) and aliquoted to minimize freeze–thaw.
  • Solubility and stability can vary widely depending on scaffold; empirical solubility screening (DMSO, DMF, ethanol, aqueous cosolvent) is recommended prior to assay deployment.

Always defer to the SDS and the item’s CoA for authoritative physical property data and handling limits.

Quality and Grades
  • Item-specific grade information

    • Grade: Moligand™ (as provided). This denotes inclusion in a small-molecule ligand/screening set intended for discovery workflows and biochemical/biophysical assays. It does not imply pharmaceutical or clinical suitability.
    • Research use: For research use only.
  • What Moligand-grade typically implies (general guidance; not a specification)

    • Sourcing and library format appropriate for HTS, fragment/ligand screening, and SAR-by-catalog efforts.
    • Packaging optimized for chemical stability and sample integrity during shipment and long-term storage (often sealed under inert atmosphere or as dry films; consult CoA for exact format).
    • Trace documentation enabling compound ID tracking (CAS/CID/lot), with CoA providing purity, identity confirmation methods, and solvent of final rinse if applicable.
  • Purity and stabilizers

    • Purity percentage, residual solvents, stabilizers, and analytical thresholds are not specified for this item; refer to CoA/Spec Sheet.
  • Practical notes for users

    • On receipt, verify lot identity against your screening database (CAS 216167-92-9; CID 9875498).
    • Record aliquotting and freeze–thaw cycles to maintain data integrity across screening campaigns.
    • If orthogonal quality checks are required (e.g., LC/MS purity, HRMS, NMR), perform upon receipt and document results for your cheminformatics records.
Reaction and Applications
  • Item-specific applications

    • Manufacturer Applications: Not specified beyond inclusion in a small-molecule/compound library (Moligand™). Suitable for ligand discovery, HTS, biochemical/biophysical screening, and early SAR exploration.
  • Discovery workflows (general guidance)

    • Biochemical assays: Evaluate concentration–response curves from DMSO stocks; include counterscreens for assay interference (e.g., redox cycling, aggregation).
    • Biophysical assays: Consider DSF, MST, SPR, ITC, or NMR ligand-observed methods to confirm direct binding where relevant.
    • Cellular assays: Assess cytotoxicity windows and permeability as needed; confirm target engagement with orthogonal readouts.
    • Hit triage: Deploy orthogonal analytical QC (LC/MS purity, HRMS) and re-purchase/resynthesize confirmation to validate hits.
  • Practical tips

    • Minimize freeze–thaw cycles of stock solutions; aliquot upon initial dissolution.
    • Include detergent (e.g., 0.01–0.05% nonionic surfactant) in assay buffers to reduce nonspecific aggregation artifacts.
    • Utilize PAINS and nuisance filter sets judiciously; do not discard potential actives without confirmatory experiments.

Note: Specific reaction chemistry (named reactions, synthetic transformations) is not discussed here because Camobucol’s structure and functional groups are not provided in the product data.

Reaction Conditions

Item-specific reaction conditions are not applicable here because the structure and functional groups of Camobucol are not provided.

General guidance for handling small-molecule library compounds in solution (not specifications)

  • Stock preparation: Dissolve in anhydrous DMSO at 10–50 mM; vortex and, if needed, sonicate briefly. Filter through 0.2 µm PTFE for particulate removal.
  • Working concentrations: Typical biochemical assays operate at 0.1–50 µM final compound concentrations with ≤1% DMSO v/v.
  • Stability checks: Monitor by LC/MS after storage or multiple freeze–thaw cycles to confirm integrity.

If you intend to use Camobucol in synthetic reactions, first obtain the structural data from the CoA and consult literature precedents for the specific chemotype.

Safety and Handling

Safety details specific to Camobucol are not present in the provided product data. Treat as a research-use small molecule of unknown hazard profile unless otherwise specified.

  • Item-specific hazard data
    • Signal word: Not specified for this item; refer to SDS.
    • H-statements: Not specified for this item; refer to SDS.
    • GHS classification/pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (best practice; defer to SDS for authority)

  • PPE: Wear lab coat, safety glasses, and appropriate gloves (e.g., nitrile). Use in a chemical fume hood to avoid inhalation of dust or vapors.
  • Avoidance: Prevent contact with skin, eyes, and clothing. Avoid inhalation of dust/aerosols. Do not ingest. Wash thoroughly after handling.
  • Incompatibilities: Without a disclosed structure, avoid strong oxidizers, strong acids/bases, and reactive reducing agents until compatibility is known.
  • Spills: Absorb small spills with inert material (e.g., vermiculite), collect in a labeled waste container. Ventilate area and avoid dust generation.
  • First aid (overview):
    • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
    • Skin/eye contact: Rinse with water for at least 15 minutes; remove contaminated clothing; seek medical attention as needed.
    • Ingestion: Rinse mouth; do not induce vomiting unless directed by medical personnel.
  • Waste: Dispose of via organic chemical waste streams in accordance with institutional and regulatory requirements.

Always consult the product’s SDS for definitive hazard and response information.

Solvent Selection

Because the exact structure and polarity of Camobucol are not provided, select solvents using general best practices for small-molecule screening compounds.

  • Item-specific note

    • Solubility data are not specified for this item; refer to CoA/Spec Sheet.
  • General solvent guidance (literature/practice)

    • Primary stock solvent: Anhydrous DMSO is the default for HTS and biochemical assay stocks due to broad solubilizing power and assay compatibility at low final v/v (≤1–2%).
    • Alternative organic solvents: DMF, ethanol, isopropanol, or acetonitrile may be used depending on scaffold compatibility and downstream assay tolerance.
    • Aqueous delivery: Prepare DMSO concentrates and dilute into buffered media with surfactant or cosolvent if needed; pre-wet plasticware to mitigate adsorption for hydrophobic compounds.
    • Degassing/filtration: For sensitive assays, 0.2 µm filtration of working solutions and gentle degassing can improve reproducibility.
  • Quick comparison (general)

    • DMSO: Highest solvency; potential freeze–thaw precipitation; hygroscopic.
    • DMF: Good solvency; higher toxicity; less common for assay stocks.
    • Ethanol/IPA: Useful for moderately lipophilic compounds; limited solubility ceiling.
    • Acetonitrile: Low viscosity; limited for very lipophilic compounds; good LC compatibility.

Always verify solubility, stability, and assay compatibility empirically for Camobucol.

Storage and Reconstitution
  • Item-specific storage/shipping

    • Storage conditions: Store at -80°C (from Product Data).
    • Shipped in: Dry ice packs + Cold packs (from Product Data). Inspect immediately upon receipt to ensure temperature compliance.
  • Item-specific formulation details

    • Appearance, solvent content, and recommended reconstitution solvent are not specified for this item; refer to CoA/Spec Sheet.
  • General guidance for library compounds (not specifications)

    • Reconstitution: If supplied as a solid, dissolve in anhydrous DMSO to prepare concentrated stocks (e.g., 10–50 mM). If supplied pre-dissolved, maintain frozen at -80°C and minimize time at ambient temperature.
    • Aliquoting: Dispense single-use aliquots in inert, low-bind vials or plates; purge headspace with nitrogen/argon to limit oxidation/hydrolysis where relevant.
    • Freeze–thaw: Avoid repeated cycles. Track and discard aliquots after a defined number of thaws (e.g., 1–2) per your QC policy.
    • Stability checks: Periodically assess by LC/MS or HPLC to confirm identity and purity after storage.
  • Safety note

    • Follow the SDS for thawing/handling precautions and spill response. For any ambiguity in solvent choice or concentration, consult the CoA or contact technical support.
Structure and Identity

Brief overview: Camobucol is supplied as a Moligand screening compound for research use. Structural descriptors are not provided in this listing; consult the CoA/Spec Sheet for definitive identifiers.

  • Item-specific facts (from Product Data)
    • SKU: C1497582
    • Product name: Camobucol
    • CAS: 216167-92-9
    • PubChem CID: 9875498
    • Grade: Moligand™
    • Storage: Store at -80°C
    • Shipping: Dry ice packs + Cold packs
  • Structure identifiers
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general note)
    • Functional groups, ring systems, and stereochemistry are not provided in the product data. For 2D/3D structure, purity trace, and exact identifiers, see the certificate of analysis or contact technical support.
  • Category context
    • Category path: 全部 / 可售 / 小分子和化合物库 — offered as part of a small-molecule/compound library for ligand discovery and screening.
Synthetic Utility

Specific synthetic reactivity, functional-group compatibility, or named-reaction roles for Camobucol cannot be described without a disclosed structure.

General approaches for library compound utilization in synthesis (not item-specific)

  • Derivatization for SAR: If the scaffold is known from the CoA or literature, consider parallel synthesis to explore side-chain and heteroatom substitutions, guided by property targets (solubility, polarity, clearance surrogates).
  • Tagging/immobilization: For mechanism-of-action studies, attachment of linkers or photoaffinity tags (diazirine/alkyne) may enable chemoproteomics pull-downs, provided functional handles exist.
  • Probing reactivity: Establish chemotype reactivity profile (acid/base stability, nucleophile/electrophile sensitivity) through small test reactions before scale-up.

Documentation

  • Capture full analytical characterization (LC/MS, 1H/13C NMR, HRMS) before and after modifications to ensure identity and purity through synthetic campaigns.
Target Specificity

Target, selectivity profile, and binding constants for Camobucol are not provided in the supplied product data.

  • Item-specific info
    • Target(s): Not specified for this item; refer to CoA/Spec Sheet or published literature linked to CAS 216167-92-9.
    • Species reactivity/assay systems: Not specified for this item; refer to CoA/Spec Sheet.

General guidance

  • Establish specificity through orthogonal assays (biochemical vs cellular), concentration–response analysis, and competition experiments with known ligands.
  • Apply counter-screens against common off-targets relevant to your biology area to de-risk false positives.

Häufig gestellte Fragen

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 216167-92-9, the molecular formula is C33H50O4S2, and the molecular weight is 574.88 g/mol.

Benötigen Sie Hilfe bei der Auswahl der Qualität?

Unser Leitfaden zur Qualitätsauswahl behandelt Reinheit, Stabilisatorstatus und Anwendungseignung für alle Varianten in unserem Katalog.

Moligand™ Qualitätsleitfaden ansehen →

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.